Kyota Fujita

Dr. Kyota Fujita


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
HHHidenori Homma
Hidenori Homma
HTHikari Tanaka
Hikari Tanaka
KFKyota Fujita
Kyota Fujita
HOhitoshi okazawa
hitoshi okazawa
The mechanisms of neuronal cell death in neurodegenerative disease remain incompletely understood, although recent studies have made significant advances. Apoptosis was previously considered to be the only mechanism of neuronal cell death in neurodegenerative diseases. However, recent findings have challenged this dogma, identifying new subtypes of necrotic neuronal cell death. The present review provides an updated summary of necrosis subtypes and discusses their potential roles in neurodegenerative cell death. Among numerous necrosis subtypes, including necroptosis, paraptosis, ferroptosis, and pyroptosis, transcriptional repression-induced atypical cell death (TRIAD) has been identified as a potential mechanism of neuronal cell death. TRIAD is induced by functional deficiency of TEAD-YAP and self-amplifies via the release of HMGB1. TRIAD is a feasible potential mechanism of neuronal cell death in Alzheimer’s disease and other neurodegenerative diseases. In addition to induction of cell death, HMGB1 released during TRIAD activates brain inflammatory responses, which is a potential link between neurodegeneration and neuroinflammation.

1 March 2018 in Thyroid®
Verified
Journal Article
Closed access
KKKenichi Kawahori
Kenichi Kawahori
KHKoshi Hashimoto
Koshi Hashimoto
XYXunmei Yuan
Xunmei Yuan
KTKazutaka Tsujimoto
Kazutaka Tsujimoto
NHNozomi Hanzawa
Nozomi Hanzawa
YOYoshihiro Ogawa
Yoshihiro Ogawa
Background: Thyroid hormones are essential for normal development of the central nervous system (CNS). Experimental rodents have shown that even a subtle thyroid hormone insufficiency in circulating maternal thyroid hormones during pregnancy may adversely affect neurodevelopment in offspring, resulting in irreversible cognitive deficits. This may be due to the persistent reduced expression of the hippocampal brain-derived neurotrophic factor gene (Bdnf), which plays a crucial role in CNS development. However, the underlying molecular mechanisms remain unclear. Methods: We administered 0.025% (w/v) thiamazole (MMI) to dams from two weeks prior to conception until delivery and succeeded in inducing mild maternal hypothyroxinemia during pregnancy. We measured serum thyroid hormone and thyrotropin (thyroid-stimulating hormone: TSH) levels of the offspring derived from dams with mild maternal hypothyroxinemia, which were referred to as M offspring and the control offspring (C offspring). At 70 days after birth (d70), we performed several behavior tests to the offspring. We also evaluated gene expression and DNA methylation status in the promoter region of Bdnf exon IV, which is largely responsible for neural activity-dependent BDNF gene expression, in the hippocampus of the offspring at d28 and d70. Results: We found no significant differences in serum thyroid hormone or TSH levels between M and C offspring at d28 and d70. M offspring showed an impaired learning capacity in the behavior tests. Hippocampal steady-state Bdnf exon IV expression was significantly weaker in M offspring than in C offspring at d28. At d70, hippocampal Bdnf exon IV expression at the basal level was comparable between M and C offspring, however it was significantly weaker in M offspring than in C offspring after the behavior tests. We also found persistent DNA hypermethylation in the promoter region of Bdnf exon IV in the hippocampus of M offspring compared to that of C offspring, which may cause the attenuation of Bdnf exon IV expression in M offspring. Conclusions: Mild maternal hypothyroxinemia induces persistent DNA hypermethylation in Bdnf exon IV in offspring as epigenetic memory, which may result in long-term cognitive disorders.

1 March 2020 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
SYShin-Sheng Yang
Shin-Sheng Yang
TITakayoshi Ishida
Takayoshi Ishida
KFKyota Fujita
Kyota Fujita
YNYuta Nakai
Yuta Nakai
Takashi OnoTakashi Ono
Takashi Ono
HOhitoshi okazawa
hitoshi okazawa
Polyglutamine tract-binding protein 1 (PQBP1), an intellectual disability causative gene, is involved in transcriptional and post-transcriptional regulation of gene expression in animals, and possibly also in plants. In our previous work, reduced brain size, associated with an elongated cell cycle duration in neural stem cells (NSCs), was observed in the NSCs conditional Pqbp1 gene knockout (cKO) mice, which mimic microcephaly patients. However, the physiological significance of PQBP1 in bone metabolism has not been elucidated. Here, we analyzed the bone phenotype of nestin-Cre Pqbp1-cKO mice. Surprisingly, the Pqbp1-cKO mice were significantly shorter than control mice and had a lower bone mass, shown by micro-computed tomography. Furthermore, bone histology showed impaired bone formation in the Pqbp1-cKO mice as well as a chondrocyte deficiency. Real-time PCR analysis showed reduced osteoblast- and chondrocyte-related gene expression in the Pqbp1-cKO mice, while the osteoclast-related gene expression remained unchanged. These results suggest that PQBP1 in bone marrow mesenchymal stem cells may play a crucial role in bone formation and cartilage development. (C) 2020 Published by Elsevier Inc.